Heart valve maturation is achieved by the organization of extracellular matrix (ECM) and the distribution of valvular interstitial cells. However, the factors that regulate matrix components required for valvular structure and function are unknown. Based on the discovery of its specific expression in cardiac valves, we aimed to uncover the role of Krox20 (Egr-2) during valve development and disease.
Introduction
Aortic valve (AoV) disease is a major health concern, with an occurrence of 2.5% of the population in the developed world. 1, 2 AoV disease manifests as stenosis and/or regurgitation (or insufficiency), and is characterized in part by the disorganization of the extracellular matrix (ECM) in the leaflets of the valve. 1, 3 AoV stenosis, an obstruction of the cardiac outflow tract (OFT), is the most common form of valvular disease, evolving into angina, syncope, or heart failure. The aetiology of AoV disease is relatively undefined; however, there is recent evidence suggesting that adult valve disease may originate in anomalies of valve development. 1 During embryonic development, the cardiac valves arise from endocardial cushions that form in the atrioventricular (AV) canal and OFT regions of the looped heart. 1 The AV cushions give rise to the mitral and tricuspid valves, whereas the aortic and pulmonary valves (semilunar valves) arise from OFT cushions. Cushion formation initiates with expansion of the cardiac jelly, the ECM residing between the myocardium and the endocardium, followed by epithelial-to-mesenchymal transformation of endocardial cells. The development of the semilunar valve is distinguished from formation of AV valve by the colonization of OFT cushions by neural crest (NC)-derived cells. 4 -6 Subsequently, endocardial cushions remodel to form thin cardiac valves. After birth, mature heart valves have a complex structure consisting of highly organized ECM. Functional components of the heart valves comprise endothelial cells at the external surfaces and the deep valvular interstitial cells, as well as the ECM. Interstitial cells are responsible for maintaining the extracellular scaffold of the valves. Semilunar valves comprise spongiosa (proteoglycan), fibrosa (collagen), and ventricularis (elastin) layers. 7 AV valves have an additional atrialis layer (elastic fibres) beneath the atrial surface. The ECM composition of the valve determines its structural and biomechanical properties. 8, 9 The collagen matrix of healthy AoV is predominantly Type I (70%), with significant amounts of Type III (25%). 10 Hence, abnormal collagen gene expression is associated with altered structural integrity of the valves. 9, 11 However, the mechanisms involved in the transcriptional regulation of collagen genes in developing valve primordia remain unknown.
The transcription factor Krox20 (also called Egr2) is a member of the early growth response family that shares a highly conserved DNAbinding domain composed of three zinc-finger motifs that bind to a GC-rich consensus sequence. Studies of Krox20 2/2 mice have shown that this transcription factor plays a key role in the development and segmentation of the hindbrain, 12, 13 and in myelogenesis by controlling Schwann cell differentiation. 14 In humans, mutations in KROX20/EGR2 are associated with severe peripheral myelinopathies, such as Dejerine-Sottas disease (MIN 145900) and Charcot -Marie-Tooth (CMT) disease type 1D (MIN 607678). 15, 16 More recently, this transcription factor has been shown to be involved in the regulation of several collagen genes in tendon cells and long bones at the cartilage-trabecular bone transition line. 17 -19 There is increasing evidence that common regulatory pathways are shared during heart valve, cartilage, tendon, and bone development. 11 In this study, we show that Krox20 is required for cardiac valve development. Using in vivo imaging, we demonstrate that adult mutant mice have aortic dysfunction associated with thickening and disorganization of ECM within the AoV leaflets. We further reveal that Krox20 regulates collagen fibril production by direct activation of Col1a1 and Col3a1 proximal promoters in embryonic day (E) 18.5 AoV. Our study thus provides new mechanistic insights into the activation of fibril-collagen genes during the formation of the AoV.
Methods

Animal experiments
This work was approved by the 'comité d'éthique pour l'expérimentation animale' (Marseille Animal Care Committee; Protocol N8. and conformed to the Directive 2010/63/EU of the European Parliament. Krox20 lacZ mice 12 were intercrossed with the Tie2-Cre mice 20 to generate heterozygous offspring that were obtained at expected Mendelian ratios. Heterozygous Tie2-cre;Krox20 lacZ/+ males were mated with Krox20 flox/+ mice 21 to generate targeted offspring (Tie2-cre;Krox20 lacZ/flox ). After echocardiographic analysis, adult Tie2-Cre;Krox20 lacZ/flox mice were sacrificed via intraperitoneal injection of pentobarbital sodium (150 mg/kg). Heart samples were harvest, fixed in 4% paraformaldehyde, and stored in 1× phosphate-buffered saline. Krox20 Cre , Gt(ROSA)26Sor tm4(ACTB-tdTomato,-EGFP)Luo (Rosa Tomato-GFP ), Gt(ROSA)26Sor tm9(CAG-tdTomato)Hze (Rosa tdTomato ), and Wnt1-Cre mice were also utilized. For reference of all the mouse lines used in this study, see Supplementary material online, Methods.
Human AoV tissue procurement and processing
All work with human samples conforms to the Declaration of Helsinki. This study was performed in accordance with the institutional guidelines and was approved by the local research ethics committee at the University Hospital of Marseille (n82013-A01020-45). Written consent was obtained from all participants involved in this study. AoV tissue was collected from three transplanted patients, as controls, and four AoV prolapse patients from elective surgery (age 23 -58). The RNA quantification protocol is provided in Supplementary material online, Methods.
Histological and immunohistochemistry
Standard protocols were used for H&E, Masson's trichrome, alcian blue, orcein, and X-gal staining of paraformaldehyde-fixed embryos. Immunohistochemistry was performed on paraffin or cryosections. Details can be found in Supplementary material online, Methods. Statistical tests used are described in Supplementary material online, Methods.
Echocardiography
In vivo valve structure and function were evaluated using a high-frequency scanner (Vevo2100 VisualSonics, Inc.). At least, 10 mice per genotype were analysed for our study. Mice were anaesthetized with 1 -2% isofluorane inhalation and placed on a heated platform to maintain their temperature during the analysis. Two-dimensional imaging was recorded with a 40 MHz transducer to capture long-and short-axis projections with guided M-Mode, B-Mode, and colour and pulsed-wave Doppler. Doppler interrogation was performed on the semilunar valve outflow in the parasternal longaxis view to assess stenosis and regurgitation using a sample volume toggle to optimize the angle of interrogation. Details can be found in Supplementary material online, Methods. Statistical significance was determined using Student's t-test as P , 0.05.
Real-time quantitative PCR and ChIP-quantitative PCR
Details of procedures and primer sequences are provided in Supplementary material online, Methods.
Western blotting
AoV tissues were extracted using the NucleoSpin RNA/Protein kit (Macherey-Nagel). Equal amounts of the total protein were mixed with a 2× protein loading dye and loaded onto 4 -12% SDS -PAGE protein gel (Life Technologies). Gels were blotted onto nitrocellulose membranes (BioRad) and probed for various antibodies (see Supplementary material online for details). Immunopositive bands were detected with Licor Odyssey Scanner, and images were analysed and normalized to loading controls using the Image J software to quantify the band intensities.
Electron microscopy
Ultra-thin glutaraldehyde-fixed sections (80 nm) were generated using a UCT ultra-microtome (Leica). Sections were analysed with an electron microscope (912; Carl Zeiss, Inc.), and the images were taken with a camera (Bioscan 792; GATAN) using the digital micrograph software. For more details, see the Supplementary material online, Methods. Quantification of the number of collagen fibres per surface was performed on four animals per genotype using the Image J software. Student's t-test was used on four mice per genotype.
Statistical analysis
All parametric data are expressed as mean + SEM. Statistical significance was determined using Student's t-test to compare variances. For non-parametric data, the Mann-Whitney test was used to calculate significance between the medians. A P-value of ,0.05 was considered significant.
Results
Krox20 is expressed in a subset of mesenchymal cells of embryonic, postnatal, and adult heart valves
Although Krox20 has been extensively studied during early development, its expression in the heart has never been fully described. To evaluate the expression of Krox20 in the heart, we carried out in situ hybridization and immunohistochemistry on wild-type, Krox20 lacZ/+ , and Krox20 GFP(DT)/+ embryos. First expression of Krox20 was observed in endocardial cushions of the OFT and AV canal at E11.5 (data not shown). At E13.5, Krox20 and reporter proteins (b-gal and GFP) were detected in the distal tip region of embryonic semilunar and AV valve leaflets ( Figure 1A, B , E, and F; see Supplementary material online, Figure S1 ). At E17.5, Krox20 was expressed on the ventricular aspect of the AoV leaflets and the distal tip of the mitral valve (MV) leaflets ( Figure 1C , D, G, and H; see Supplementary material online, Figure S1 ). Immunohistochemistry for Krox20 revealed a restricted expression in the valvular mesenchymal cells ( Figure 1I and J ), as well as in the endothelial cells ( Figure 1J ). At E17.5, Krox20 was more prominent in valvular interstitial cells situated in the subendocardial regions of the valves. Krox20 was also detected in quiescent valvular interstitial cells as indicated by co-localization with very low level of a-smooth muscle actin (a-SMA) ( Figure 1K and L).
Genetic lineage tracing analysis was evaluated using Krox20 Cre mice. 13 At E17.5, Rosa tdTomato reporter activity was detected in cells located at the ventricular aspect of the AoV leaflets and the distal tip region of the MV leaflets (see Supplementary material online, Figure S1 ). Krox20 descendant cells were located in the collagen-rich fibrosa layer of E17.5 AoV leaflets (see Supplementary material online, Figure S1 ). Interestingly, expression of Krox20 was also observed in postnatal and adult heart valves, with predominance for the AoV. Collectively, these findings indicate that Krox20 is expressed in progenitor endothelial/mesenchymal cells and subsequently in valvular interstitial cells of embryonic, postnatal, and adult heart valves. and anti-Krox20 (green) antibodies reveals that nuclear Krox20 protein is predominantly expressed in the mesenchymal cells. However, co-localization of Krox20 and Pecam is occasionally found in endothelial cells (arrowhead in inset). (K and L) At E17.5, immunohistochemistry with anti-a-SMA (red) and anti-Krox20 (green) displays expression of Krox20 at the subendocardial region of the AoV (K ) and MV (L). Infrequent co-localization of Krox20 with a-SMA is observed in a small number of valvular interstitial cells (arrowheads in insets). lv, left ventricle; OFT, outflow tract. Scale bars: 100 mm (A-L).
Krox20 is required for aortic valve development
Loss of Krox20 results in abnormal semilunar valve morphology
Histological analysis revealed dysmorphic and enlarged AoV leaflets in 12/12 (100%) Krox20 lacZ/lacZ (Krox20 2/2 ) mice, but not in controls (11/11 ; Figure 2A and B). In contrast, no obvious anomalies were observed in the AV valves ( Figure 2C and D). Morphometric analysis confirmed that the aortic and pulmonary valve leaflets were more thickened than the AV valve leaflets ( Figure 2E , P ¼ 0.00007, Student's t-test). Three-dimensional (3D) reconstructions of the AoV underlined this enlargement ( Figure 2F and G), and quantification of the 3D volume showed that mutant AoVs were 1.8 times larger than the controls ( Figure 2H , P ¼ 0.0039, Mann-Whitney test). These data were confirmed by the measurement of the relative surface ( Figure 2I , P ¼ 0.0065, Mann-Whitney test).
To understand the mechanism underlying AoV enlargement, we quantified the total number of AoV cells. At E18.5, the average number of mesenchymal cells in the mutant was increased by 30% over that in controls ( Figure 2J , P ¼ 0.014, Student's t-test). These changes were also observed at E15.5, but not earlier (see Supplementary material online, Figure S2 ). Besides the increase of mesenchymal cells, quantification of cell density was somewhat reduced in E18.5 Krox20 2/2 embryos compared with littermates ( Figure 2K , P . 0.05, Mann-Whitney test), suggesting that expansion of the intercellular space may also participate in the enlargement of the semilunar valve leaflets. Since remodelling of the semilunar valves is associated with a decrease in mesenchymal proliferation and an increase in apoptosis, 1 we examined these parameters. A time course of cell proliferation was assessed by the percentage of phospho-histone H3-positive cells at E13.5, E15.5, and E17.5. We did not detect a statistically significant difference in proliferation at these stages (see Supplementary material online, Figure S2 ). We next assessed if there was a deficiency in apoptosis. At E17.5, caspase-3 staining showed no difference between Krox20 2/2 is significantly increased in the mutant compared with the controls. (J ) Total nuclei were counted in the AoV leaflets from Krox20 2/2 and control embryos at E18.5 spanning a 180 mm depth. The mean of the total nuclei per leaflet demonstrates a significant increase in the mutant. (K ) The number of cells per relative leaflet area is slightly reduced. All measures were calculated from n ¼ 6 embryos for each genotype. Histograms are expressed as mean + SEM (*P , 0.05, Student's t-test or Mann-Whitney test as described in the text). lv, left ventricle; PV, pulmonary valve; TV, tricuspid valve. Scale bars: 100 mm.
(n ¼ 3) and control (n ¼ 3) embryos (0.30 + 0.03 vs. 0.38 + 0.03%; 9089 mesenchymal cells counted). These results indicate that, at least at E17.5, apoptosis of mesenchymal cells is not affected in Krox20 2/2 semilunar valves.
To evaluate whether increased mesenchymal cells correspond to cells expressing Krox20, we counted cells positive and negative for GFP activity using the Krox20 GFP(DT) allele. At E18.5, Krox20 GFP(DT)/lacZ AoV leaflets (n ¼ 3) exhibit 18.2% of GFP + cells, which was comparable with that observed in Krox20 GFP(DT)/+ (n ¼ 4) embryos (16.8%, P . 0.05), suggesting a non-cell autonomous function of Krox20 in the hypercellular leaflet phenotype. Genetic fate-mapping studies demonstrated that mesenchymal cells in the semilunar valves are derived from the endocardium and NC cells. 4, 5, 7, 22 To assess the contribution of these lineages, we analysed the endothelial-and NC-derived cells in Tie2-Cre;Rosa Tomato-GFP and Wnt1-Cre;Rosa Tomato-GFP mice, respectively. 5, 20, 23 At E18.5, we did not detect difference in the contribution of endothelial derivatives (data not shown), whereas NC-derived cells appeared more numerous in the semilunar valve leaflets of Krox20 2/2 compared with controls (see Supplementary material online, Figure S2 ). Hence, this analysis indicates accumulation of NC derivatives and suggests that this increase may contribute to enlargement of the semilunar valve leaflets in the absence of Krox20.
Krox20 mutant mice display AoV dysfunction
To study the cardiac function of Krox20 mutants at the adult stage and to avoid the early lethality found in Krox20 mutant animals, 12 we used the Tie2-Cre transgene 20 to mediate recombination of a loxP-flanked allele of Krox20 21 specifically in endothelial-derived cells. This Cre driver line was chosen based on co-localization of Krox20 with the reporter activity observed using the Tie2-Cre;Rosa TdTomato line (see Supplementary material online, Figure S1 ). Tie2-Cre;Krox20 lacZ/flox (Krox20 cKO ) mice were observed at the expected Mendelian ratios (10.1%, n ¼ 208; Supplementary material online, Table 1 ) and were viable. We assessed valve function by echocardiography at 3 months of age. Pulse-wave Doppler analysis of the aorta showed flow reversal in 100% (11/11) of Krox20 cKO mice, but not in controls ( Figure 3A and B) . Among these mice, four had acceleration of aortic velocity suggesting an increase in aortic stroke volume and/or an obstruction across the AoV caused by thickened leaflets ( Figure 3C ; see Supplementary material online, Figure S3 ). Indeed, haemodynamic evaluation demonstrated a significant increase in aortic flow velocity (3115 + 557 vs. 997 + 32 mm/s; P , 0.0001) and pressure gradients (42 + 15 vs. 4 + 0.23 mmHg; P ¼ 0.0007) in these four Krox20 cKO mice ( Figure 3D) . This group showed a significant augmentation in left Figure 3D ). Of note, no functional anomaly of the pulmonary valve was observed in Krox20 cKO mice at 3 months of age, despite an increased thickness of pulmonary valve leaflets at E18.5. Consistent with an absence of morphological defects in the AV valves, no functional abnormalities were observed at the level of the mitral and tricuspid valves. Finally, no differences in the AoV annulus were detected in Krox20 cKO (1.60 + 0.14 vs. 1.51 + 0.16 mm). Overall, these data demonstrate that deletion of Krox20 results in dysfunction of the AoV.
Absence of Krox20 results in thickening of the AoV leaflets
Histological analysis of adult hearts showed dysmorphic and enlarged AoV leaflets in the mutant (Figure 4 ). However, morphology of the AV valve leaflets was virtually indistinguishable between mutant and controls at 3 months of age (data not shown). Anatomically, thickening of the AoV was restricted to the distal tips of the leaflets (Figure 4 ). Morphometric analysis confirmed an average of 2.17 times increase in the thickness at the distal region of the AoV leaflets in Krox20 cKO mice compared with controls ( Figure 4A , P ¼ 0.001). Consistently, the relative surface of the AoV was significantly increased in the mutant ( Figure 4B , P ¼ 0.0005). Additionally, the number of interstitial cells of the AoV was augmented with an average of 1.97 times ( Figure 4C , P , 0.0001). There was also a dramatic increase in the intercellular space throughout the mutant leaflets compared with controls as reported by the cell density ( Figure 4D , P ¼ 0.00001). Overall, these data indicate that the enlargement of the AoV leaflets in the mutant is not only caused by an augmentation of the number of valvular interstitial cells within the leaflets, but also by an expansion of the space between those cells.
Abnormal AoVs are associated with ECM disorganization
In Krox20 cKO mice, histopathology with Masson's trichrome, alcian blue, and orcein stains demonstrated a disorganization of the ECM (Figure 4 ; see Supplementary material online, Figure S4 ). Specifically, decrease of collagen deposition in the distal thickened region of the AoV leaflets was observed in Krox20 cKO mice, as indicated by diffuse blue staining ( Figure 4G and H ). In addition, increased proteoglycan deposition was observed histologically in thickened AoV of Krox20 cKO mice (see Supplementary material online, Figure S4 ). This defect was associated with elevated expression of markers of cartilage and proteoglycan-rich tissues such as Sox9 and Hapln1 genes (see Supplementary material online, Figure S5 ). Noticeable dispersion of elastin fibres was observed in the mutant (see Supplementary material online, Figure S4 ). Therefore, the AoV leaflets of Krox20 cKO mice have all features of human myxomatous valve disease. 24 The morphological changes in the defective AoV of Krox20 cKO mice were assessed by transmission EM (Figure 5) . Collagen, proteoglycan, and elastin fibres are usually observed in the fibrosa, spongiosa, and ventricularis layers of the valve, respectively ( Figure 5A-C) . In Krox20 cKO mice, ECM layers appeared expanded ( Figure 5D) , and the number of collagen fibres was reduced ( Figure 5E and F) . Although not statistically significant, quantification of the number of collagen fibres per unit surface area displayed a reduction of 1.7 times in the mutant valves ( Figure 5G) , suggesting that Krox20 may be involved in the production of collagen fibres. Krox20 is required for aortic valve development Several collagen classes including fibril-, network-, and beaded filamentforming, and fibril-associated collagens are required to maintain valve structure and function. 1, 11 Quantitative real-time (qRT)-PCR from AoV tissues isolated at 3 months of age confirmed a down-regulation of several fibril-forming collagens including Col1a1, Col1a2, and Col3a1 genes within Krox20 cKO vs. controls mice ( Figure 5H ; see Supplementary material online, Figure S6 ). Interestingly, a similar decrease was found at P8 (see Supplementary material online, Figure S6 ). These observations suggest that the decrease of collagen fibres in the mutant mice is directly caused by a transcriptional diminution rather than by protein degradation through the activity of MMPs. 1, 8, 11 Indeed, Mmp1 and Mmp3 levels were unchanged in Krox20 cKO (see Supplementary material online, Figure S7 ). As proteoglycans appeared abundant within the spongiosa layer and that this layer was expanded within the AoV leaflets of adult Krox20 cKO hearts, we quantified their expression level. Expression of several chondroitin sulfate proteoglycan (CSPG) genes including neurocan, aggrecan, and versican was significantly up-regulated within the Krox20 cKO AoV ( Figure 5I) . Western blot analysis using a pan-CSPG antibody confirmed this increase ( Figure 5J) . These results indicate that Krox20 regulates the ECM by maintaining the homeostasis between the different components of this matrix.
Loss of Krox20 during embryogenesis disrupts collagen homeostasis within the mature valve
To understand the mechanism that leads to variations in collagen composition identified in adult Krox20 cKO mice, we examined their expression during valve development at E13.5 and E18.5. Whereas no difference was detected at E13.5 (see Supplementary material online, Figure S8 ), gene expression level changes were observed at E18.5 for the AoV (Figure 6A and B; see Supplementary material online, Figure  S9 ). These variations included significant decreases in Col1a1, Col1a2, Col3a1, Col5a1, Col6a1, and Col12a1 mRNA levels ( Figure 6A and B; see Supplementary material online, Figures S9 and S10) . Noticeable, qRT-PCR analysis did not reveal differences in collagen gene expression in the MV of Krox20 2/2 mice (see Supplementary material online, Figure  S11 ), consistent with the absence of morphological and functional anomalies. Remarkably, our observations revealed that decrease of Col1a1, Col1a2, and Col3a1 gene expression in the AoV was robust since it was observed at embryonic, postnatal, and adult stages. As expected, decrease of Col1a1, Col1a2, and Col3a1 mRNA levels was associated with a reduction in Type I and III collagen proteins ( Figure 6C-F) . Reduction in Type I collagen a-1 and a-2 was also confirmed by western blot analysis ( Figure 6G and H ) . Taken together, our data demonstrate that Krox20 is required to control the expression levels of fibril-forming collagens Types I and III in the forming semilunar valves.
Krox20 regulates transcription of Col1a1 and Col3a1 proximal promoters in the AoV
To further understand the transcriptional regulation of Col1a1 and Col3a1 in the AoV, we examined the promoter region of these genes. Thus, several evolutionary conserved consensus Krox20-binding sites (GNGTGGGNG) were found in Col1a1 and Col3a1 proximal promoters ( Figure 7A ). Next, we examined the interaction of Krox20 with these putative-binding sites using electrophoretic mobility shift assay (EMSA; Figure 7B ), and found that Krox20 was able to bind these Krox20 motifs with moderate or high affinity, but was not competent to bind mutated Krox20 motifs ( Figure 7B) . Several promoter -reporter constructs were generated to perform luciferase assays. As shown in Figure 7C , the shorter reporter constructs pGL3-Col1-1100 (bp +111 to 21024) and pGL3-Col3-600 (bp +174 to 2498), which lack three or one consensus binding sites, respectively, showed decreases in luciferase activity, compared with the full-length constructs (pGL-Col1-3200, bp +111 to 23200 and pGL3-Col3-1300, bp +174 to 21198). Site-directed mutagenesis was used to eliminate one Krox20 putative-binding sequence of pGL3-Col1-3200 and pGL3-Col3-1300 (see Supplementary material online, Methods). In luciferase assays, loss of the Krox20-binding site in pGL3-Col1 and pGL3-Col3 essentially eliminated and reduced transactivation by Krox20, respectively ( Figure 7C) . In vivo chromatin immunoprecipitation (ChIP) experiments were performed using freshly dissected, E18.5 murine AoV and ventricular tissues. The amount of immunoprecipitated DNA relative to input chromatin was determined by quantitative PCR (qPCR) using primers flanking the Krox20-binding sites we had identified in the Col1a1 and Col3a1 proximal promoters (Figure 7) . ChIP-qPCR demonstrated enrichment of binding within the B and C regions of Col1a1 and Col3a1 in the AoV extracts ( Figure 7D and E) . No interaction with Krox20 was observed for an adjacent region, which does not include a Krox20 consensus sequence. Despite a relatively high level binding of Krox20 to K3-and K4-motifs ( Figure 7B) , enrichment was not observed for regions A and D within the Col1a1 and Col3a1 promoters, The DNA-binding specificity of Krox20 was tested by mutating each site: K1 mt (TTgacgAC), K2mt (GTGatttAA), K3mt (CAaaatCAC), K4mt (CTGatttTT), and K5mt (GAGatttTG). Sites K1 and K3 for Col1a1 and K5 for Col3a1 bind to Krox20 with higher affinity than K2 and K5, respectively. (C) Schematic representation of the Col1a1 and Col3a1 reporter constructs (left panel). Reporter assays using indicated reporter constructs and an expression vector bearing Krox20 (right panel). Cos7 cells were transiently co-transfected with 200 ng of indicated constructs, 10 ng of control pGL4.74(hRluc/TK) vector, and 300 ng of CMV-Krox20 expressing vector. Data are represented as a fold change in luciferase activity normalized to Renilla. *P , 0.05 using the Student's t-test. (D and E) qPCR showing significant enrichment of DNA/Krox20 complexes on Krox20-binding sites within the Col1a1 and Col3a1 proximal promoters following ChIP using freshly dissected AoVs and left ventricles (LV) from E18.5 hearts. Anti-Histone H3 was used as a positive control of immunoprecipitation. Primers used for qPCR correspond to Col1a1 or Col3a1 proximal promoter regions (Col1a1-A, Col1a1-B, Col3a1-C, and Col3a1-D), as identified in (A), and primers in region without Krox20-binding sites (no-binding sites) were used as negative controls. Relative quantities of each chromatin-bound fragment were normalized relative to the amount of input DNA. Note significant enrichment in regions B and C within the Col1a1 (D) and Col3a1 (E) promoters, respectively. All experiments were performed in triplicate and expressed as mean + SEM (*P , 0.001, Student's t-test; NS, not significant).
Krox20 is required for aortic valve development respectively, suggesting that Krox20 does not interact with these binding sites in the AoV (Figure 7D and E). Enrichment of region C within the Col3a1 proximal promoter was consistent with the luciferase activation assay. Overall, these data demonstrate that the Col1a1 and Col3a1 genes include a conserved Krox20-containing regulatory element bound by Krox20 in the AoV and transactivated by Krox20 in an Krox20-motif dependent manner in transfected cells.
Diseased human AoVs display decreased expression of COL1A2 associated with reduction in KROX20
To determine the expression of KROX20 (named EGR2 in human) and its downstream target genes in thickened human AoVs, we obtained explanted valve tissue from adult patients at the time of valve replacement. Severe aortic regurgitation was the indication for surgery in all cases. Control valve tissues were obtained during cardiac transplantation from patients with end-stage heart failure and no evidence of AoV disease. Transcriptional levels of KROX20, COL1A1, COL1A2, and COL3A1 were assessed by qRT-PCR. We found a variable, but consistent, reduction of KROX20 expression in all diseased AoVs compared with controls ( Figure 8A ). Among the fibrillar collagen genes tested, only COL1A2 was found to be significantly decreased in diseased valves compared with controls ( Figure 8B and data not shown) . This finding demonstrates that pathological AoVs leading to severe aortic regurgitation in human have decreased KROX20 expression.
Discussion
AoV disease, which is characterized by alteration of valvular interstitial cell distribution and disorganization of the ECM, 1 occurs in 2.5% of the general population and often requires surgical intervention. The precise mechanisms involved in this pathology, including the identification of transcription factors responsible for the control of matrix gene expression, have not been elucidated to date. Thus, it is critical to fully understand the transcriptional regulation of AoV disease if effective therapies are to be designed. In this study, we provide evidence that Krox20 is involved in AoV development, and that it is necessary to regulate the expression of fibrillar collagen genes in the AoV at embryonic and adult stages.
Krox20 a novel animal model to study AoV disease
The absence of Krox20 leads to dysmorphic and thickened AoV leaflets that are functionally incompetent. Histology shows that these defects are associated with a disorganization of the ECM and an abnormal distribution of valvular interstitial cells. These features are similar to characteristics of human AoV myxomatous disease, but also of other mouse models including osteogenesis imperfecta murine (oim) and Periostin (Postn) mice. 25, 26 The molecular basis of the valve phenotype of Krox20 mutant mice appears more similar to oim than Postn mice. Indeed, the semilunar valves of Krox20 and oim mutant mice are specifically affected with insignificant AV valve involvement. In addition, thickness of the semilunar valves in Krox20 and oim mutant mice is restricted to the distal region of the leaflets, whereas Postn null mice show an increase in the medial region of the valve. 25 Expression of Col2a1 is augmented in adult Krox20 mutants (see Supplementary material online, Figure S6 ) as also observed in oim 2/2 mice. 25 These findings highlight similarities between Krox20 and oim mutant mouse models.
Oim mutant mice have a spontaneous mutation in the Col1a2 gene. 25 Similarly, human patients with Osteogenesis Imperfecta (OI), which is associated with mutations in the COL1A1 or COL1A2 genes, have a predisposition to AoV disease. 27, 28 Col1a1 and Col1a2, encode, respectively, a1 and a2 chains, which are required to form Type I collagen. While Type I collagen is the major component of collagen fibrils, other fibrillar collagens such as Type III and V collagens are also important for the formation of collagen fibres. 10 In Krox20 2/2 embryos, a decrease in Type I and III collagens is principally detected in the distal region of the AoV leaflets, where Krox20 is primarily expressed. Type I and III collagens form banded fibrils and provide tissues with tensile strength. 9 Therefore, fibrillar collagens are crucial for the flexibility of the AoV leaflets in diastole. 8 Like human OI patients, AoV regurgitation is observed in Krox20 mutant mice, associated with an obvious AoV defect. Thus, we postulate that the AoV pathology identified in the absence of Krox20 is essentially caused by a reduction in the fibrillar collagens.
Krox20 is a direct activator of Col1a1 and Col3a1 promoters
Our data support a model of direct regulation of Col1a1 and Col3a1 transcription by Krox20. First, the absence of Krox20 activity affects the transcriptional level of Col1a1 and Col3a1 at embryonic and adult stages. Secondly, the 3.2 and 1.2 kb proximal promoters of Col1a1 and Col3a1, respectively, contain multiple conserved sequences that constitute putative sites for Krox20 binding. EMSA show that Krox20 can bind several of these sites, a result confirmed by in vivo quantitative ChIP analysis notably in the AoV, where Krox20 is strongly bound to regions B and C of the Col1a1 and Col3a1 promoters, respectively. Thirdly, in transient transfection experiments, overexpression of Krox20 has transactivation effects on reporter constructs containing 23.2-kb 5 ′ to the Col1a1 or 21.2-kb 5 ′ to the Col3a1 promoters. Consistently, when K2 or K5 motifs are mutated, transactivation is significantly decreased for Col1a1 and Col3a1 promoters, respectively. These data demonstrate direct regulation of Col1a1 and Col3a1 by Krox20.
Although Krox20 regulates Col1a1 and Col3a1 genes, their transcript levels are drastically down-regulated but not totally absent in Krox20 2/2 embryos, indicating that other factors activate these collagen genes. The basic helix-loop-helix transcription factor Scleraxis (Scx) would be a good candidate, because like Krox20 it has been shown to activate Col1a1 transcription in the tendons. 18, 29 Moreover, a recent study has demonstrated a molecular interaction and transactivation of Scx with E-box sites within the proximal promoter region of COL1A2 in cardiac fibroblasts. 30 Expression of Scx is not detected during initial stage of valve development; however, by E16.5, Scx is expressed in the semilunar valves. 31 This stage is associated with changes in ECM distribution and organization. 11 In addition, we detected a normal expression of Scx in cardiac valves of Krox20 mutant mice (data not shown). Therefore, expression of Scx in the AV valves would explain the normal expression of collagen genes in Krox20 2/2 MV. Although differences in Type I collagen production has not been reported in Scx 2/2 mice, 32 we speculate that Scx may participate together with Krox20 in the regulation of fibrillar collagens during valve development. Nevertheless, such activation would be interesting to assess.
Krox20 is specifically required during semilunar valve development
In our study, we demonstrate that although Krox20 is detected in all heart valves, its loss of function affects specifically the semilunar valves. Consistently, assessment of adult valve function reveals an aortic regurgitation but normal function of the MV. In addition, qRT-PCR analysis shows a down-regulation of several collagen genes in the AoV, but not in the MV of the mutant. As proposed above, other transcription factors may compensate the absence of Krox20 in the AV valves, but not in the semilunar valves. Another argument is that Krox20 is predominantly expressed in the semilunar valves evoking the importance of Krox20 expression for these valves. Interestingly, phenotypes specifically affecting the semilunar valves have been reported in other mouse models including Oim, Adam17, and Egfr. 25, 33, 34 Like Krox20, these genes are expressed in both semilunar and AV valves, suggesting that the semilunar valves are highly sensitive to the absence of these factors. Alternatively, the difference of phenotype may be due to divergence in the origin of these valves. Indeed, semilunar valve development is distinguishable from AV valve development by the presence of mixed endocardial-and NC-derived mesenchymal cells. 4, 5, 7, 22, 35 At E13.5, all three AoV leaflets have contribution from NC-derived cells, but by E16.5 there is considerable decreased. 5, 22, 35 Interestingly, Phillips et al. 35 observed few bgal+ cells in the AoV of Wnt1-Cre;R26R embryos at postnatal day 21, suggesting that some NC-derived cells persist in the semilunar valve leaflets after birth. Our fate-mapping analysis reveals that NC derivatives appear more abundant in Krox20 2/2 AoV leaflets than the controls. In addition, our quantification of GFP-positive cells in Krox20 GFP(DT)/lacZ valves indicates a non-cell autonomous function of Krox20 in the hypercellular leaflet phenotype. Jain et al. have shown the role of NC-derived cells in orchestrating the remodelling and maturation of seminular valves. Therefore, a surplus of NC-derived cells in Krox20 AoV leaflets may contribute to the valvular phenotype. Reduction of NC-derived cells in the semilunar valves is currently associated with an increase of apoptosis by E15.5. 22 Despite no obvious difference of cell death at E17.5, we cannot exclude that signals controlling apoptosis in the semilunar valve leaflets may be disrupted in the absence of Krox20 at earlier stages. Coordinate interactions between endothelial-and NC-derived mesenchymal cells are likely important for semilunar valve development. 6, 22, 36 Hence, disorganization of the ECM would have an effect on the communication between these cells types too. Nevertheless, the identification of signals required for apoptosis of NC-derived cells will be of great interest.
Valvular interstitial cells are a heterogeneous and dynamic population that maintains the extracellular scaffold of the valve. 1 This population derives from mesenchymal cells that populate the valve leaflets during development. The contribution of NC-and endothelial-derived cells to matrix components and, subsequently to the trilaminar ECM organization of the valves remains unclear. Reduction in NC cells leads to dysmorphic and thickened semilunar valves associated with an excess of ECM, suggesting that balance between NC-and endothelial-derived cell composition is important for the structure of the valve leaflets. 22 Despite an apparent increase in NC-derived cells, a reduction of collagen fibres is observed in Krox20 mutant AoV leaflets, suggesting that NC-derived cells do not contribute to collagen in the mature semilunar valves. Nevertheless, the contribution of NC-and endothelial-derived mesenchymal cells to collagen, proteoglycan, and elastin layers should be addressed by lineage tracing or targeted ablation.
Deletion of Krox20 results in abnormal AoV leaflets, which are characterized by an increase in mesenchymal/interstitial cell number. Quantification of cell density shows a reduction in the number of nuclei per square millimetre, suggesting that enlargement of the AoV leaflets is also associated with an expansion of the ECM. Histological and quantitative analyses demonstrate increased proteoglycan deposition. qRT-PCR reveals an increase of Hapln1 expression in adult Krox20 mutant AoV, which is consistent with the stabilization of proteoglycan aggregates and the augmentation of surface area. 37 In myxomatous valve leaflets, changes in ECM abundance are associated with an abnormal excess of CSPGs. 38 Thus, we speculate that the thickening of the distal valve leaflets is primarily due to increased proteoglycan deposition. Although there has been little investigation of the up-regulation of specific types of proteoglycans in diseased valves, we hypothesize that reduction of fibrillar collagens in the distal region of Krox20 mutant valve may contribute to the increase of proteoglycan gene expression. Alternatively, the overabundance of proteoglycans may be secondary to increased mesenchymal/interstitial cell number.
KROX20 in human valves
In human, mutations in KROX20 (EGR2) have been found in patients with myelinopathies, such as Dejerine -Sottas disease (MIN 145900) and CMT disease type 1D (MIN 607678). 15, 16 The association between CMT disease and cardiac abnormalities is controversial. Although some investigators consider that cardiac involvement in CMT disease is fortuitous, a growing number of studies reported cardiac conduction disorders. Interestingly, one study reported MV prolapse in patients with Krox20 is required for aortic valve development CMT disease. 39 However, this study did not specify which mutations were associated with this disorder. CMT patients with mutations in KROX20 locus are very rare (,1%), contributing to the difficulty of cardiovascular diagnosis. A recent study identified homozygous deletion of a KROX20 enhancer in patients with congenital hypomyelinating neuropathy, suggesting that the regulation of KROX20 expression is crucial for normal development. 40 We cannot therefore exclude that a mutation or deletion located in an as yet unidentified cardiac regulatory region may be associated with AoV regurgitation. Interestingly, our study reveals reduced KROX20 (EGR2) expression levels in pathological AoVs in human. These valves were thickened and severe aortic regurgitation was diagnosed by Echo-Doppler before surgical replacement. This result suggests that thickening of the AoV leaflet leading to functional defect of the valve is associated with reduction in KROX20 transcription. However, the mechanism underlying this reduction is still unclear. Indeed, the down-regulation of KROX20 may be directly caused by a mutation in a cis-regulatory region, as yet unidentified, or by altered upstream signalling events associated with diseased AoVs. Our study also reveals a differential expression of fibrillar collagen genes in diseased AoVs between mouse and man. Indeed, reduction in COL1A2 expression was observed in the pathological AoVs, whereas the transcriptional levels of COL1A1 and COL3A1 were not decreased. This difference may be explained by a low conservation of Col1a1 and Col3a1 promoters between mouse and human, as observed for the Krox20-binding sites ( Figure 7A ). In addition, we cannot exclude that additional regulators of COL1A1 and COL3A1 genes are active in human pathological AoVs. Taken together, these results suggest that thickening of the AoVs may be associated with a reduction in KROX20 expression.
The present study identifies a previously unknown function of Krox20 during semilunar valve development. Deletion of Krox20 leads to an increased number of mesenchymal/interstitial cells and disorganization of the ECM through the down-regulation of the major fibrillar collagen genes. Our data highlight the potential role of Krox20 in AoV disease and provide a new model to dissect the mechanisms of human AoV pathology.
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